Prescription Drug and Alcohol Use Disorders
Edition #478 | March 2019
FP Essentials is a monthly subscription containing authoritative, unbiased, and peer-reviewed clinical information—without any advertisements.
Purchase this individual edition for online access to its content, and earn up to 5 CME credits upon completion of the quiz. Online access for this edition available until March 2021.
In This Edition
- Review and follow the Centers for Disease Control and Prevention recommendations for safe prescribing of opioids.
- Identify nonopioid first-line treatment of chronic noncancer pain.
- Summarize the criteria for diagnosing opioid use disorder and be able to distinguish it from uncomplicated opioid dependence.
- Describe why methadone, buprenorphine, and intramuscular naltrexone are the recommended pharmacotherapies for opioid use disorder.
- List some prescription and nonprescription drugs with which nonmedical use can occur.
- Describe appropriate tools to assess for nonmedical use, including drug screening tests and state prescription drug monitoring program data.
- Identify the three screening tests that are recommended when assessing for unhealthy alcohol use and choose one or more of them to screen all adults.
- Explain why acamprosate and naltrexone are firstline treatments for alcohol use disorder.
Approved for 5 AAFP Prescribed credits. Credit valid through March 14, 2021.
Purchase This Edition
Online access only
#478: Prescription Drug and Alcohol Use Disorders
CME credit approved through March 14, 2021
Take the Quiz for CME Credit
Read It Online Now
Content accessible after purchase.